Albany Times Union
The company announced the discontinuation of the trial after the markets closed. In after-hours trading, shares were off another 88 cents to $21.00.
and more »
Friday, September 11, 2009
Regeneron ends Phase 3 trial for pancreatic cancer treatment - Albany Times Union
Albany Times Union
The company announced the discontinuation of the trial after the markets closed. In after-hours trading, shares were off another 88 cents to $21.00.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment